Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Assets Average (2016 - 2025)

Capricor Therapeutics has reported Assets Average over the past 15 years, most recently at $241.2 million for Q4 2025.

  • Quarterly results put Assets Average at $241.2 million for Q4 2025, up 83.12% from a year ago — trailing twelve months through Dec 2025 was $241.2 million (up 83.12% YoY), and the annual figure for FY2025 was $263.2 million, up 129.67%.
  • Assets Average for Q4 2025 was $241.2 million at Capricor Therapeutics, up from $130.0 million in the prior quarter.
  • Over the last five years, Assets Average for CAPR hit a ceiling of $241.2 million in Q4 2025 and a floor of $39.1 million in Q1 2021.
  • Median Assets Average over the past 5 years was $52.6 million (2022), compared with a mean of $77.5 million.
  • Biggest five-year swings in Assets Average: dropped 25.74% in 2023 and later soared 227.55% in 2025.
  • Capricor Therapeutics' Assets Average stood at $42.2 million in 2021, then increased by 23.2% to $52.0 million in 2022, then fell by 7.82% to $47.9 million in 2023, then soared by 174.73% to $131.7 million in 2024, then soared by 83.12% to $241.2 million in 2025.
  • The last three reported values for Assets Average were $241.2 million (Q4 2025), $130.0 million (Q3 2025), and $143.7 million (Q2 2025) per Business Quant data.